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Adult neurogenesis is a tightly regulated process continuously taking place in the central
nervous system of most mammalian species. In neuroscience research, transgenic
animals bearing the tamoxifen-inducible CreERT2-Lox system are widely used. In this
study, we made use of a Nestin-CreERT2/R26R-YFP transgenic mouse model in which
the CreERT2 activates the expression of YFP in multipotent neural stem cells upon
tamoxifen application. Humoral factors, such as the levels of estrogens, have been
reported to affect the hippocampal neurogenesis. The application of tamoxifen, a mixed
agonist/antagonist of the estrogen receptor that permeates the blood-brain-barrier, could
thus influence adult neurogenesis. Although the functions of adult neurogenesis are yet
to be fully deciphered, a reciprocal interaction between rates of neurogenesis on the one
hand and learning and mood regulation on the other hand, has been suggested. The
impact of tamoxifen on neurogenesis and behavior was therefore addressed following five
daily applications according to the open field test, the elevated plus maze, and Morris
water maze. In addition, the impact of short-term tamoxifen application on progenitor
cell proliferation, morphology, and fate in the neurogenic niche of the dentate gyrus were
investigated. Finally, the influence of the route of administration (oral vs. intra-peritoneal)
and gender-specific response were scrutinized. The sub-acute analysis did neither reveal
significant differences in behavior, such as voluntary motor activity, anxiety behavior, and
spatial learning, nor in cell proliferation, cell survival, dendritic arborization or maturation
rate within the dentate gyrus between saline solution-, corn oil-, and tamoxifen-treated
groups. Finally, neither the route of application, nor the gender of treated mice influenced
the response to tamoxifen. We conclude that short tamoxifen treatments used to activate
the CreERT2 system in transgenic mouse models does not have a measurable impact
on adult neurogenesis or the here tested behavior, and is therefore appropriate for most
studies in the field.
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INTRODUCTION
In rodents, as well as in humans, adult neurogenesis takes
place in two neurogenic niches of the central nervous system:
the subgranular zone of the dentate gyrus in the hippocampus
and the subventricular zone of the lateral ventricles (Luskin,
1993; Kuhn et al., 1996). The neurogenic niches provide a
supportive environment for the key events of neurogenesis,
i.e., neural stem and progenitor cell proliferation, survival, and
integration. Moreover, numerous factors modulated the rates of
neurogenesis, e.g., growth factors, cytokines, physical activity,
stress, etc. (Kempermann et al., 1997; Couillard-Despres et al.,
2005; Villeda et al., 2011; Couillard-Despres, 2013; Aimone et al.,
2014; Rotheneichner et al., 2014; König et al., 2016). Although
the role of neurogenesis in cognition is still unclear and the
source of intensive debates (Kempermann et al., 2004; Aimone
et al., 2014; Yau et al., 2015) evidence suggests that neurogenesis
contributes to cognitive input processing (Clelland et al., 2009),
memory retention (Becker, 2005; Thuret et al., 2009), and the
reliability of memory (Wiskott et al., 2006). It is noteworthy that
the correlation between neurogenesis and cognition appears to
be bidirectional, i.e., cognitive effort and learning stimulates the
generation of new neurons as well (Gould et al., 1999).
An increasing number of transgenic tools to study adult
neurogenesis are being based on the targeted expression of the
Cre-recombinase fused with a mutated form of the estrogen
receptor (e.g., CreERT2), providing a high affinity for tamoxifen,
but a low affinity for endogenous estrogen (Feil et al., 1996,
1997; Indra et al., 1999). Upon binding of tamoxifen with the
fusion protein, the latter translocates from the cytoplasm to the
nucleus and excises genomic segments comprised between loxP
sequences. An example of such transgenic systems is the nestin-
CreERT2/R26R-YFP encoding the CreERT2 under the control of
the nestin promoter, which is active in multipotent neural stem
cells (Lagace et al., 2007). Concomitantly, this mousemodel bears
the yellow fluorescent protein (YFP) integrated in the ROSA26
locus for ubiquitous expression. Due to the presence of a loxP-
flanked STOP cassette upstream of the YFP reporter, expression
in the neural stem cells will only begin following the tamoxifen-
induced excision by the recombinase (Lagace et al., 2007).
Tamoxifen is a mixed agonist/antagonist of the estrogen
receptor. First synthesized in 1966 (Sneader, 2005), tamoxifen is
mainly used as a therapy option for breast cancer (Cole et al.,
1971; Jordan, 2003), premature puberty (Eugster et al., 1999), and
female infertility (Steiner et al., 2005). Since tamoxifen can readily
cross the blood-brain-barrier (BBB; Lien et al., 1991; Pareto et al.,
2004), it could influence processes within the central nervous
system (CNS). For instance, it was reported that patients who
received 20mg per day of tamoxifen for 5 years showed lower
cognitive and memory performances compared to untreated
patients (Paganini-Hill and Clark, 2000; Eberling et al., 2004;
Boele et al., 2015).
Transgenic mouse models based on tamoxifen-activated
recombinase systems are available since ∼2 decades and were
soon introduced in the field of neurology (Orban et al., 1992;
Metzger et al., 1995; Tsien et al., 1996). Nevertheless, the
influence of administration of the estrogen agonist/antagonist
tamoxifen per se on adult neurogenesis has not been addressed
in depth and conflicting data regarding potential influence
on learning, memory, or anxiety have been reported (Chen
et al., 2002a,b; Vogt et al., 2008; Zabihi et al., 2014; Azizi-
Malekabadi et al., 2015). In this regard, estrogens have been
previously shown to influence neurogenesis. For example in
the dentate gyrus of female rats, the number of proliferating
cells labeled by the application of BrdU is the highest during
proestrus, e.g., at the highest estrogen levels, as compared
to estrus and diestrus (Tanapat et al., 1999). On the other
hand ovariectomy did not only drastically reduce the level of
circulating estrogen, it also decreased the number of proliferating
cells in dentate gyrus. Furthermore, administration of estrogen
to ovariectomized rats improved spatial memory, a process
associated with the hippocampus (Packard and Teather, 1997;
Bimonte and Denenberg, 1999).
In the present report, we investigated the impact of tamoxifen
administration on the open field and elevated plus maze tests, as
well as the Morris water maze test. Moreover, we investigated the
impact of short-term tamoxifen application on cell proliferation,
cell survival, dendritic arborization, and maturation rate in the
granular and the subgranular zone of the dentate gyrus, as well
as the fate of the newly generated cells. In addition, the efficiency
of an oral and intra-peritoneal administration was compared and
potential gender-specific response was investigated.
MATERIALS AND METHODS
Animals
All experiments were performed in accordance to the guidelines
of the “Directive 2010/63/EU of the European Parliament and of
the Council of 22 September 2010 on the protection of animals
used for scientific purposes” and were approved by the national
animal care authorities.
This study was performed on 5 month-old nestin-
CreERT2/R26R-YFP mice (Lagace et al., 2007). All mice were
housed in groups of 2–5 mice of the same gender littermates
per cage with ad libitum access to water and food under 12 h
light/12 h dark cycle.
Experiment 1: Tamoxifen (100mg/kg bodyweight; 10mg/ml
stock solution; Sigma-Aldrich) dissolved in corn oil (Sigma-
Aldrich), or corn oil as vehicle control, was administered daily
from day 1 to 5 by intra-peritoneal injection or stomach gavage.
Experiment 2: To investigate the possible effect of corn oil
per se on proliferation and survival of newborn neurons, a
second experiment was performed on 5 month-old C57BL6 mice
which received five consecutive daily intra-peritoneal injections
of either tamoxifen (100mg/kg bodyweight), corn oil or saline
solution (0.9% NaCl). In addition, 5-bromo-2′-deoxyuridine
(BrdU; 50mg/kg bodyweight; 10mg/ml stock solution; Sigma-
Aldrich) was injected intra-peritoneal either on 1 single day
(Exp. 1), or daily from day 1 to 5 (Exp. 2) to label proliferating
cells (Figure 1A).
Histology
On day 15, mice were transcardially perfused with 0.9%
NaCl for 5min followed by 0.1 M phosphate buffered 4%
Frontiers in Neuroscience | www.frontiersin.org 2 February 2017 | Volume 11 | Article 27
Rotheneichner et al. Tamoxifen Does Not Disturb Neurogenesis
paraformaldehyde pH 7.4 for 10min. Brains were dissected
and post-fixed in the same solution overnight at 4◦C and then
transferred in 0.1M phosphate buffered 30% sucrose solution pH
7.4 at 4◦C for at least 48 h. Brains were cut in 40 µm sagittal
sections using a slidingmicrotome (Leica) on dry ice and sections
were stored at−20◦C in cryoprotectant (25% v/v glycerol, 0.05M
sodium phosphate buffer pH 7.4, 25% v/v ethylene glycol) until
processing.
Immunohistological analyses were performed as previously
described (Couillard-Despres et al., 2005) using the following
antibodies and kits: chicken anti-GFP (Invitrogen, 1:500), rabbit
anti-DCX (Cell Signaling Technology, 1:300), mouse anti-NeuN
(Millipore, 1:500), rat anti-BrdU (AbD Serotec, 1:500), mouse
anti-PCNA (Santa Cruz Biotechnology, 1:500), donkey anti-
chicken Alexa 488 (Jackson Immuno Research, 1:1000), donkey
anti-rabbit Alexa 568 (Invitrogen, 1:1000), donkey anti-rat
Rhodamin Red (Jackson Immuno Research, 1:1000), donkey
anti-rat Cy5 (Jackson Immuno Research, 1:1000), donkey anti-
mouse Alexa 647 (Invitrogen, 1:1000), rabbit anti-rat biotinylated
(Vector Laboratories, 1:1000), donkey anti-mouse biotinylated
(Jackson Immuno Research, 1:1000), goat anti-rabbit biotinylated
(Vector Laboratories, 1:1000), VECTASTAIN ABC System and
DAB Peroxidase Substrate kit (Vector Laboratories) and 4′6-
diamidino-2-phenylindole (DAPI, Sigma-Aldrich, 0.5 µg/ml).
The total number of labeled cells in the granular and
subgranular layer of the dorsal dentate gyrus per hemisphere
was extrapolated using stereological techniques on every fifth or
every tenth section (Couillard-Despres et al., 2005). Bright-field
micrographs were acquired with an IX81 microscope (Olympus)
using the Volocity Software (Perkin Elmer). Fluorescent
micrographs were obtained and analyzed with a LSM 700
confocal microscope and ZEN 2011 Black Software (Carl Zeiss)
and ImageJ Software 1.46r (National Institutes of Health, USA).
For morphological analysis immature neurons were identified
by their expression of doublecortin (DCX+). Bright-field
micrographs were acquired with a Nikon Eclipse E600
microscope (objective: 100×/1.3 oil). For each investigated
DCX+ cell a minimum of three images of different focal
planes was taken and merged using Helicon Focus 6 software.
Individual neurites were traced using ImageJ (Schneider et al.,
2012) in combination with the NeuronJ plugin (Meijering et al.,
2004). Primary neurite length was determined and groups were
compared using one-way ANOVA. For each group a minimum
of six mice was taken to perform morphological analysis of
DCX+ cells.
Behavioral and Cognitive Tests
Open Field
The open field test for spontaneous motor activity was performed
on day 8 and analyzed using a tracking software (EthoVision
2.3.19, Noldus). Mice were given 5min for free exploration on
a circular arena of 100 cm diameter. Arena was cleaned between
each trial to avoid olfactory cues.
Elevated Plus Maze
The elevated plus maze test was performed on day 8 to evaluate
the anxiety level of mice. The maze was set 50 cm above floor
level and presented four arms (50 × 10 cm), two opened and
two closed arms with walls of 40 cm height. Maze was cleaned
between each trial. Mice were given 5min of free exploration
starting in the central intersection facing an open arm. Tracking
software (EthoVision 2.3.19, Noldus) was used to record and
analyze behavior of the mice in the maze during the trial.
Morris Water Maze
The Morris water maze test was used to assess spatial learning
and memory. The maze consisted in a 108 cm round basin filled
with 20 cm deep water (21 ± 1◦C) made opaque with milk
powder. A 10 × 10 cm square platform located 1 cm below
the surface was positioned in the maze. Big black cue symbols
were put on the each wall of the testing room for orientation
and the experimental setup was not changed throughout the
learning session. Water maze trials (maximum 60 s) for learning
were performed twice a day for a total of 10 trials from day
8 to 12 after first tamoxifen administration using one of four
starting quadrant selected randomly. Before starting the learning
experiment each mouse was put in the water and given 60 s to
swim and locate the submerged platform. If the platform was not
detected within 60 s the animal was guided onto the platform
and allowed to remain there for 10 s. On day 12, an additional
memory paradigm was performed by removing the platform and
mice were tracked for 60 s. The swim path and velocity was
recorded (EthoVision 2.3.19, Noldus) for every session. In the
absence of the platform during the last session, the time spent
in the platform quadrant and the “frequency of crossing” at the
exact former position of the platform was additionally calculated.
Statistics
Statistical analyses were performed using two-tailed unpaired
T-test with a 95% confidence interval (GraphPad PRISM 5.0,
GraphPad Software Inc.). The learning curves of theMorris water
maze test, the comparison of the number of BrdU+ cells in
relation to the duration of BrdU+ administration were analyzed
using a two-tailed one-way or two-way ANOVA with Bonferroni
post-hoc test. For the analysis of the proportions of BrdU+/DCX+
and BrdU+/NeuN+, as well as BrdU+/DCX+/NeuN+ cells
between the different groups a Chi2-test was used. Graphs show
mean values with standard deviation as error bars. Significance
was p > 0.05 ns, p < 0.05∗, p < 0.01∗∗, and p < 0.001∗∗∗.
RESULTS
Impact of Short Tamoxifen Treatments on
Motor Activity, Anxiety, and Spatial
Learning
Spontaneous motor activity was evaluated in the open field test
according to the total distance covered during a 5min trial on
day 8. Mice treated with tamoxifen for 5 consecutive days did
not show significant difference in the total distance covered
compared to corn oil treated groups (3251± 662 cm corn oil (n=
23) vs. 3020 ± 881 cm tamoxifen (n = 24), p = 0.32; Figure 1B),
or the saline solution treated groups (data not shown). Similarly,
no significant differences associated with gender or route of
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FIGURE 1 | (A) Experimental plan of tamoxifen (TAM) and BrdU administration and behavioral tests. BrdU was injected intra-peritoneal either for 1 day, or for 5
consecutive days (#). TAM was administered intra-peritoneal or by gavage on 5 consecutive days. Behavioral tests (Plus Maze =', Open Field = , Water Maze
Learning =©L , and Water Maze Memory =©M ) were performed from day 8 to 12. Mice were perfused on day 15. (B) Total distance covered in the open field test
shows no significant differences in locomotion comparing corn oil and tamoxifen treatment groups. (C,D) The comparison of corn oil and tamoxifen treatment groups
in the time spent in the open arm of the elevated plus maze and the number of entries in the open arms reveals no significant differences in levels of anxiety. The same
result was observed by comparing the saline solution-treated group with either corn oil-treated or tamoxifen-treated mice (data not shown). (E,F) Gender-specific
analysis of elevated plus maze data revealed significant differences in anxiety levels of females compared to males according to the time spent in open arms (p =
0.0065**) and number of open arm entries (p = 0.0465*). (G–I) Learning and memory performances were analyzed using the Morris water maze test. (G) Learning
curve (time to find the platform) from day 8 to 12 revealed no learning differences between corn oil and tamoxifen treated mice, as analyzed by two-way ANOVA.
Following removal of the platform on day 12, no differences in memory according (H) to the time spent in platform quadrant and (I) number of platform crossings were
noticed between the tamoxifen and corn oil treated mice, as well as the saline-treated animals (data not shown).
administration were detected within or between the treatment
groups (data now shown).
The elevated plus maze test is a well-established method to
evaluate the anxiety level according to the preference for open
or closed arms (Pellow et al., 1985). Analyses performed on day
8 revealed no significant differences between the corn oil- or
tamoxifen-treated groups in regard to time spent in open arms
[73 ± 38 s corn oil (n = 23) vs. 84 ± 52 s tamoxifen (n =
24), p = 0.43; Figure 1C], in the number of open arm entries
[15 ± 5 corn oil (n = 23) vs. 15 ± 5 tamoxifen (n = 24) p
= 1.00; Figure 1D], nor in the total distance covered [1781 ±
297 cm corn oil (n = 23) vs. 1707 ± 335 cm tamoxifen (n =
24), p = 0.42]. Similarly, no significant differences were found
between saline solution-treated groups and tamoxifen-treated
groups (data not shown). However, females spent more time in
open arms and entered open arms more frequently compared
to males irrespective of treatment and route of application [time
spent in open arms 95± 51 s females (n= 26) vs. 59± 29 s males
(n = 21), p = 0.0065∗∗ Figure 1E; number of open arm entries
16 ± 5 females (n = 26) vs. 14 ± 5 males (n = 21), p = 0.0465∗
Figure 1F].
Morris water maze test (two trials daily) was performed from
days 8 to 12 to assess spatial learning. The time required to find
the hidden platform decreased from day 8 to 12 in both corn oil-
and tamoxifen-treated groups (corn oil n = 23; tamoxifen n =
24; p < 0.0001∗∗∗; Figure 1G). No significant difference of time-
to-platform could be detected between the treatment groups (p
= 0.64). No significant differences associated with gender or
administration route were observed for these parameters within
or between the treatment groups (data now shown).
On day 12, spatial memory was further assessed during a 60 s
trial by measuring the total time spent in the platform quadrant,
as well as frequency of crossing the platform area, following
removal of the platform from the basin. No significant differences
in the time spent inside the platform quadrant [27 ± 9 s corn oil
(n = 23); 27 ± 7 s tamoxifen (n = 24), p = 0.93; Figure 1H], or
in the number of crossing of the platform area [4 ± 2 corn oil (n
= 23) and 4 ± 2 tamoxifen (n = 24), p = 0.99; Figure 1I] could
be detected between the corn oil- and tamoxifen-treated groups.
Similarly, no significant difference could be detected between
saline-solution treated groups and corn oil-treated groups, as well
as between saline solution-treated groups and tamoxifen-treated
groups (data not shown). No significant differences associated
with gender or administration route were observed for these
parameters within or between the treatment groups (data not
shown).
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Impact of Tamoxifen on Hippocampal
Neurogenesis
The number of cells proliferating at the time of perfusion (day
15) was estimated based on the expression of the proliferation
marker PCNA. The number of PCNA+ cells detected in the
dorsal dentate gyrus did not significantly differ between corn oil-
, saline- and tamoxifen-treated mice [487.5 ± 151.6 cells saline
(n = 8); 453.3 ± 118.1 cells corn oil (n = 9); 423.8 ± 177.5
cells tamoxifen (n = 8), p = 0.6995; Figure 2A]. No significant
differences associated with gender or administration route were
observed in the number of PCNA-labeled cells within or between
the treatment groups (data now shown).
We further scrutinized the survival of newly generated cells
labeled with BrdU either administered on day 1, or for 5
consecutive days, still remaining in the dorsal dentate gyrus after
2 weeks. Corn oil-treated mice retained 199 ± 96 BrdU+ cells,
whereas 162 ± 69 cells were detected in the tamoxifen-treated
mice after 1 day BrdU administration (corn oil n= 15; tamoxifen
n = 17; p = 0.23; Figure 2B). Moreover, BrdU administration
for 5 consecutive days did not lead to any significant differences
in BrdU+ cell numbers between saline solution-, corn oil-, and
tamoxifen-treated mice [saline solution: 1563± 180 BrdU+ cells
(n = 9); corn oil: 1538 ± 502 BrdU+ cells (n = 10); tamoxifen:
1413 ± 351 BrdU+ cells (n = 10); p = 0.75; Figure 2B].
Similarly, no significant differences associated with gender or
administration route were observed in the number of surviving
BrdU-labeled cells within or between the treatment groups (data
now shown).
Morphology of DCX+ cells was analyzed by semi-automatic
individual neurite tracing (Meijering et al., 2004) and compared
between all three groups using one-way ANOVA. The primary
neurite length of DCX+ cells in the dorsal dentate gyrus did
not differ significantly between saline solution-, corn oil-, and
tamoxifen-treatedmice [saline solution: 25.4± 14.5µm (n= 22);
corn oil: 34.3± 15.8 µm (n= 20); tamoxifen: 32.0± 14.0 µm (n
= 19); one-way ANOVA of the groups p= 0.14; Figures 2G,H].
In addition, we scrutinized the fate of the newly generated cells
labeled with BrdU for 5 consecutive days. Neither the percentage
of cell adopting a neuronal fate, as determined by the expression
of DCX, nor the rate of neuronal maturation visualized by
the induction of NeuN expression were affected by tamoxifen
treatment compared to the saline as well as corn oil-treated group
[saline: 493 DCX+ cells, 108 DCX+/NeuN+ cells, 30 NeuN+ cells
(total n= 729 cells), corn oil: 502 DCX+ cells, 73 DCX+/NeuN+
cells, 20 NeuN+ cells (total n= 665 cells); tamoxifen: 441 DCX+
cells, 60 DCX+/NeuN+ cells, 24 NeuN+ cells (total n= 604 cells);
Chi2-test p = 0.07; Figures 2C,D]. There were no significant
differences associated with gender or route administration in the
fate of BrdU+ cell, either within or between the treatment groups
(data now shown).
Impact of Tamoxifen’s Route of
Administration
Although no differences in voluntary motor activity, anxiety
behavior, spatial learning, and neurogenesis have been detected
between mice receiving intra-peritoneal or gavage tamoxifen
applications on 5 consecutive days, it remained to be determined
if both routes of administration activate the CreERT2 system
to the same extent. Two weeks following five daily applications
of tamoxifen, we observed 255 ± 216 cells expressing YFP in
the dorsal dentate gyrus of mice injected intra-peritoneal (n =
4). Administration by gavage resulted in an equivalent number
of labeled cells (351 ± 189, n = 9, p = 0.43; Figures 2E,F).
Gender-specific analysis did not show significant differences of
recombination efficacy (data not shown).
DISCUSSION
Transgenic animal models are widely used in the field of
neurosciences and tamoxifen-inducible CreERT2-Lox systems
constitute an innovative and elegant method to activate or
deactivate genes at a specific time point. However, in order to
correctly interpret the function of the targeted gene, it is crucial to
determine potential impacts of tamoxifen per se on behavior and
neural processes. In this report, we used a Nestin-CreERT2/R26R-
YFP mouse model (Lagace et al., 2007) to address the sub-
acute impact of short-term tamoxifen administration on the adult
hippocampal neurogenesis and behavior, i.e., open field, elevated
plus maze, and Morris water maze tests. The latter three address
voluntary motor activity, anxiety behavior, and spatial learning,
respectively.
In this study, mice were perfused and analyzed 2 weeks
after five daily applications of tamoxifen or vehicles, such as
corn oil or saline solution. At this time point, no difference
between the treatment groups in the number of cells proliferating
(PCNA+) could be detected in the subgranular zone of the
dorsal dentate gyrus where neural progenitors reside. Similarly,
within the dentate gyrus, survival of newly generated cells
labeled with BrdU for either one or 5 consecutive days did not
differ between the two treatment groups. Furthermore, fate and
maturation rate of the newly generated cells appeared similar in
the three treatment groups arguing against a significant lasting
influence of tamoxifen on adult hippocampal neurogenesis.
Moreover, no significant differences in the morphology of the
immature hippocampal neurons could be detected between saline
solution-treated mice and neither the corn oil nor the tamoxifen
groups. Despite our histological observation in the dentate
gyrus, tamoxifen administration could provoke neurogenesis-
independent modification of behavior and spatial learning.
Consistent with a previous report (Vogt et al., 2008), none of
the parameters investigated using our behavioral test battery
indicated differences between the tamoxifen and the two vehicle-
treated groups. This observation supports the hypothesis that
short-term tamoxifen application, as well as short-term corn
oil application does not influence behaviors when assessed at a
sub-acute time point and therefore will not interfere with most
experimental readouts.
Taken that tamoxifen interacts with the estrogen receptor, we
further scrutinized for putative gender-specific differences in our
readout parameters. Our analysis substantiated an earlier report
showing that females were less anxious in the elevated plus maze
test, as compared to males (Võikar et al., 2001). This difference,
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FIGURE 2 | Immunohistological analysis of (A) cell proliferation (PNCA+) and (B) survival (BrdU+) in the dorsal dentate gyrus revealed no differences between
saline, corn oil and tamoxifen treated mice after single BrdU administration or a BrdU administration for 5 consecutive days. (C) Chi2-Test showed independency of
cell fate of BrdU+ cells between saline, corn oil, and tamoxifen treated mice comparing the number of cells expressing DCX and/or NeuN on day 15. (D)
Representative immunohistological staining of the dentate gyrus showing BrdU-labeled (red) immature neurons expressing DCX (green) and the surrounding mature
neurons detected with anti-NeuN (white; scale bar = 50 µm). (E) Analysis of the number of cells expressing YFP in the dorsal dentate gyrus revealed no significant
differences in the efficacy of CreERT2 activation via intra-peritoneal administration of tamoxifen compared to gavage. (F) Representative detection of YFP using a DAB
staining in the granular layer of the dentate gyrus showing YFP+ radial glia-like cells (scale bar = 20 µm). (G) DAB staining in the granular layer of the dentate gyrus
identified DCX+ immature neurons enabling individual tracing of primary neurites (end of primary neurite marked with red arrow; scale bar = 20 µm). (H) Analysis of
the primary neurite length of DCX+ immature neurons within the dentate gyrus revealed no significant morphological difference between saline solution-, corn oil-, and
tamoxifen-treated mice.
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however, was independent of the treatment received. Apart
from this gender-associated difference in anxiety, no further
differences betweenmales and females could be recognized in the
other behavioral and histological parameters investigated.
Finally, we compared two alternative routes of tamoxifen
administration, i.e., the intra-peritoneal injection and oral
gavage. Detailed analyses did not reveal significant differences
in behaviors or adult neurogenesis associated with the route
of application, given the sub-acute time point analyzed here.
Furthermore, we compared the respective efficacy of CreERT2
activation based on the number of cells expressing the reporter
gene YFP in the dentate gyrus and we could not detect a
significant difference associated with the route of tamoxifen
application.
In conclusion, within the time-frame investigated, no
differences in adult hippocampal neurogenesis or spontaneous
motor activity, anxiety, and spatial learning could be identified
in mice that previously received tamoxifen on 5 consecutive
days, as compared to vehicle-treated mice. The equivalent
efficiency in CreERT2 activation following intra-peritoneal
and oral administration of tamoxifen argues for an oral
application as first choice, since the corn oil used as vehicle
for tamoxifen accumulates in the abdominal cavity for at least
2 weeks following intra-peritoneal application which could
lead to local inflammation. In summary, we conclude that
the short-term application of tamoxifen does not significantly
interfere with adult neurogenesis or anxiety and spatial
learning when assessed at the sub-acute time point tested
here. This allows for the use of available CreERT2-Lox
systems in their full potential for the investigation of adult
neurogenesis.
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